Pepsin detection in the sputum/saliva for the diagnosis of gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal reflux disease symptoms

Digestion

Volumn 77, Issue 3-4, 2008, Pages 201-206

  Kim, Tae Ho ^a   Lee, Kwang Jae ^a,b   Yeo, Marie ^a   Kim, Dong Kyu ^a   Cho, Sung Won ^a  

^a Ajou University School of Medicine   (South Korea)

^b Ajou University Medical Center   (South Korea)

Author keywords

Atypical GERD symptoms; Esophageal pH monitoring; Pepsin; PPI test

Indexed keywords

ESOMEPRAZOLE; PEPSIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; PRIORITY JOURNAL; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PEPSIN A; PROSPECTIVE STUDIES; SALIVA; SENSITIVITY AND SPECIFICITY; SPUTUM;

EID: 50149104779     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000143795     Document Type: Article

References (29)

1. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-1456.
2. Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G: Natural history of gastroesophageal reflux disease and functional abnormal disorders: a population-based study. Am J Gastroenterol 2001;96:2905-2914.
3. Haque M, Wyeth JW, Stace NH, Talley NJ, Green R: Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. NZ Med J 2000;113:178-181.
4. Isolauri J, Laippala P: Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 1995;27:67-70.
5. Kennedy T, Jones R: The prevalence of gastrooesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000;14:1589-1594.
6. Louis E, DeLooze D, Deprez P, et al: Heart-burn in Belgium: prevalence, impact on daily life, and utilisation of medical resources. Eur J Gastroenterol Hepatol 2002;14:279-284.
7. Katz PO, Castell DO: Approach to the patient with unexplained chest pain. Am J Gastroenterol 2000;95:S4-S8.
8. Ing AJ, Ngu MC, Breslin AB: Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Respir Crit Care Med 1994;149:160-167.
9. Koufman JA: The otolaryngologic manifestations of gastroesophageal reflux disease: a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101(suppl 53):1-78.
10. Harding SM: Gastroesophageal reflux as an asthma trigger: acid stress. Chest 2004;126:1398-1399.
11. Lewin JS, Gillenwater AM, Garrett JD, Bishop-Leone JK, Nguyen DD, Callender DL, Ayers GD, Myers JN: Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx. Cancer 2003;97:1010-1014.
12. Wong WM, Fass R: Extraoesophageal and atypical manifestations of GERD. J Gastroenterol Hepatol 2004;19:S33-S43.
13. Richter JE: Extraoesophageal manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 22(suppl 1):70-80.
14. Ronkainen J, Aro P, Storskrubb T, et al: High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005;40:275-285.
15. Fass R: Erosive esophagitis and non-erosive reflux disease: comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol 2007;41:131-137.
16. Richter JE: Extraesophageal presentations of gastroesophageal reflux disease: an overview. Am J Gastroenterol 2000;95(suppl 8):S1-S3.
17. Cremonini F, Wise MSJ, Moayyedi P, Talley NJ: Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a meta-analysis. Am J Gastroenterol 2005;100:1226-1232.
18. Wang WH, Huang JQ, Zheng GF, et al: Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain? Arch Intern Med 2005;165:1222-1228.
19. Johnston N, Knight J, Dettmar PW, Lively MO, Koufman J: Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope 2004;114:2129-2134.
20. Knight J, Lively MO, Johnston N, Dettmar PW, Koufman JA: Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux. Laryngoscope 2005;115:1473-1478.
21. Vaezi MF: The role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2006;23(suppl 1):40-49.
22. Piper DW, Fenton BH: pH stability and activity curves of pepsin with special reference to their clinical importance. Gut 1965;6:506-508.
23. Johnston N, Dettmar PW, Bishwokarma B, Lively MO, Koufman J: Activity/stability of human pepsin: Implications for reflux attributed laryngeal disease. Laryngoscope 2007;117:1036-1039.
24. Johnston N, Dettmar PW, Lively MO, et al: Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and HSP70) response: role in laryngopharyngeal reflux disease. Ann Otol Rhinol Laryngol 2006;115:47-58.
25. Richter JE: Extraesophageal presentations of gastroesophageal reflux disease: an overview. Am J Gastroenterol 2000;95(suppl 8):S1-S3.
26. Meert KL, Daphtary KM, Metheny NA: Detection of pepsin and glucose in tracheal secretions as indicators of aspiration in mechanically ventilated children. Pediatr Crit Care Med 2002;3:19-22.
27. Badellino MM, Buckman RF Jr, Malaspina PJ, et al: Detection of pulmonary aspiration of gastric contents in an animal model by assay of peptic activity in bronchoalveolar fluid. Crit Care Med 1996;24:1881-1885.
28. Krishnan U, Mitchell JD, Messina I, et al: Assay of tracheal pepsin as a marker of reflux aspiration. J Pediatr Gastroenterol Nutr 2002;35:303-308.
29. Potluri S, Friedenberg F, Parkman HP, et al: Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, pharynx, and lung. Dig Dis Sci 2003;48:1813-1817.